Terms: = Bone cancer AND uPA AND Staging
6 results:
1. Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma.
Paule B; Deslandes E; Le Mouel SP; Bastien L; Podgorniak MP; Allory Y; de la Taille A; Menashi S; Calvo F; Mourah S
Int J Biol Markers; 2010; 25(2):112-5. PubMed ID: 20544684
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic and predictive factors revisited.
Hayes DF
Breast; 2005 Dec; 14(6):493-9. PubMed ID: 16239111
[TBL] [Abstract] [Full Text] [Related]
3. [Detection and clinical significance of plasma urokinase-type plasminogen activator and its soluble receptor in patients with multiple myeloma].
Luo LH; Xu GB; Lu XG
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 32(6):529-32. PubMed ID: 14712519
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival.
Kasimir-Bauer S; Schleucher N; Weber R; Neumann R; Seeber S
Oncol Rep; 2003; 10(2):475-82. PubMed ID: 12579292
[TBL] [Abstract] [Full Text] [Related]
5. An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion.
Simon C; Nemechek AJ; Boyd D; O'Malley BW; Goepfert H; Flaitz CM; Hicks MJ
Laryngoscope; 1998 Nov; 108(11 Pt 1):1686-91. PubMed ID: 9818827
[TBL] [Abstract] [Full Text] [Related]
6. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.
Heiss MM; Allgayer H; Gruetzner KU; Babic R; Jauch KW; Schildberg FW
Ann Surg; 1997 Dec; 226(6):736-44; discussion 744-5. PubMed ID: 9409572
[TBL] [Abstract] [Full Text] [Related]
